William McVicar Net Worth & Insider Trades

William McVicar - Director, Salarius Pharmaceuticals, Inc

As of January 5, 2023

What is William McVicar's Net Worth?

The current estimated net worth of Salarius Pharmaceuticals, Inc's Director, William McVicar, is estimated to be about $12.09K . William McVicar owns about 26,553 units of Salarius Pharmaceuticals, Inc common stock. In the last 3 years at Salarius Pharmaceuticals, Inc, William McVicar has sold an estimated value of $0 worth.

What is William McVicar's Past Insider Trading?

William McVicar's largest purchase order was 8,700 units , worth over $10.01K on February 12, 2020. In total, William McVicar has made about 6 transactions over 3 years of their time at Salarius Pharmaceuticals, Inc. William McVicar usually trades in February and January, with the busiest year in 2020. The most recent transaction was a purchase order of 26,553 units , worth over $5K on June 7, 2022.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

William McVicar

Date Range: All Time
Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...

InsideArbitrage

Our partner InsideArbitrage provides a full suite of tools and analysis that allows you to find opportunities from the hundreds of insiders transactions filed by company insiders each week. The service includes the popular Insider Weekends articles that highlight the top 5 insider purchases and sales each week as well as detailed analysis of one company each week. The service also includes several custom screens such as the Double Dipper that includes a list of companies that are buying back their shares while their insiders are independently buying stock on the open market for their own portfolios.

What is William McVicar's' Mailing Address?

  • Mailing address is C/o Inotek Pharmaceuticals Corporation 131 Hartwell Avenue, Suite 105 Lexington MA 02421 MA

What are Salarius Pharmaceuticals, Inc's Past Insider Trades?

Salarius Pharmaceuticals, Inc's most recent insider trade came on June 8, 2022 by Tess Burleson who bought 27,700 units worth $4.99K . In the last 3 years, insiders at Salarius Pharmaceuticals, Inc have bought an estimated value of $0 worth of shares. Insider trading is most common in February, with the busiest year in 2020. The most active traders at the company are David Arthur, Chief Executive Officer,  Mark J Rosenblum, Exec VP Finance,  and Arnold C Hanish, Director .

Salarius Pharmaceuticals, Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
Loading...